摘要
目的:探讨短暂性脑缺血发作患者血浆溶血磷脂酸(LPA)水平变化及不同剂量阿司匹林治疗效果。方法:选取我院2008年10月~2010年12月收治的短暂性脑缺血患者80例为研究组,选择同期同年龄段健康体检者80例为对照组,观察两组LPA水平差异。研究组患者分别给予阿司匹林25mg/d(A组),75mg/d(B组)、200mg/d(C组),观察不同剂量阿司匹林对患者LPA水平及短暂性脑缺血发作的影响。结果:研究组患者血浆LPA水平明显高于对照组,两组比较,差异有统计学意义(t=8.726,P〈0.05),研究组患者治疗后A、B、C组LPA水平均较治疗前下降。但B、C组治疗前后比较,差异有统计学意义(t=5.169、8.874,P〈0.05),A组治疗前后比较,差异无统计学意义(t=0.726.P〉0.05)。三组治疗后LPA水平及3个月内脑缺血内发作次数C组最少,B组次之,A组最多,三组间比较,差异有统计学意义(F=7.649、8.021,P〈0.05)。结论:短暂性脑缺血发作患者血浆溶血磷脂酸水平明显升高,高剂量阿司匹林可明显减少血浆溶血磷脂酸水平及脑缺血发作次数:在无禁忌证的情况下可作为临床治疗的有效方法。
Objective: To investigate the changes of lysophosphatidic acid (LPA) levels in transient ischemic attack (TIA) patients and the effect of different doses of Aspirin. Methods: 80 TIA patients in our hospital from October 2008 to De- cember 2010 were selected as the study group, the healthy persons in the same period of the same age were chosen as con- trol group, LPA levels of the two groups were observed. Patients in the study group were given Aspirin 25 mg/d (group A), 75 mg/d (group B), 200 mg/d (group C), the impact of different doses of Aspirin on LPA levels and cerebral ischemia attack were observed. Results: Plasma LPA level of the study group was significantly higher than that of the control group, the difference was statistically significant (t=8.726,/)〈0.05); LPA level of study group after treatment all significantly de- creased than before treatment, However, that of B, C group was significantly lower than before treatment (t=5.169, 8.874, P〈0.05), and there was no significant difference of LPA level of group A before and after treatment (t=0.726, P〉0.05). After treatment, levels of LPA and ischemic attack number in 3 months were the most in group A, followed by group B, and the lest in group C, the difference of the three groups was statistically significant (F=7.649,8.021, P〈0.05 ). Conclusion: LPA level of TIA patients is significantly high, high-dose Aspirin can significantly reduce the LPA level and the number of is- chemic attack, with no contraindications, it can be an effective treatment way.
出处
《中国医药导报》
CAS
2011年第31期62-63,共2页
China Medical Herald